iSpecimen Inc. Operating Cash Flow
iSpecimen Inc. (ISPC) reported Operating Cash Flow of -$4.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- iSpecimen Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$689.63K.
- iSpecimen Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.36M.
- iSpecimen Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$916.92K.
- iSpecimen Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.04M.
- iSpecimen Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$4.24M.
- iSpecimen Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$8.26M.
- iSpecimen Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$5.81M.
- iSpecimen Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$5.82M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$689.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$4.05M 10-Q · filed 2026-08-14 | -$4.97M derived: sum of 3 quarters · filed 2026-08-14 | -$7.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$3.36M 10-Q · filed 2026-05-18 | -$4.28M derived: sum of 2 quarters · filed 2026-05-18 | -$6.31M derived: sum of 3 quarters · filed 2026-05-18 | -$6.51M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$916.92K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$2.95M derived: sum of 2 quarters · filed 2026-04-01 | -$3.14M derived: sum of 3 quarters · filed 2026-08-14 | -$4.24M 10-K · filed 2026-04-01 |
| 2025-09-30 | -$2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$2.23M derived: sum of 2 quarters · filed 2026-08-14 | -$3.32M 10-Q · filed 2025-11-17 | -$6.90M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$192.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.29M 10-Q · filed 2026-08-14 | -$4.86M derived: sum of 3 quarters · filed 2026-08-14 | -$5.94M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.10M 10-Q · filed 2026-05-18 | -$4.67M derived: sum of 2 quarters · filed 2026-05-18 | -$5.75M derived: sum of 3 quarters · filed 2026-05-18 | -$7.29M derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | -$3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$4.65M derived: sum of 2 quarters · filed 2026-04-01 | -$6.19M derived: sum of 3 quarters · filed 2026-04-01 | -$8.26M 10-K · filed 2026-04-01 |
| 2024-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | -$2.62M derived: sum of 2 quarters · filed 2025-11-17 | -$4.69M 10-Q · filed 2025-11-17 | -$4.35M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$3.61M 10-Q · filed 2025-08-14 | -$3.27M derived: sum of 3 quarters · filed 2025-08-14 | -$4.90M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$2.07M 10-Q · filed 2025-05-19 | -$1.73M derived: sum of 2 quarters · filed 2025-05-19 | -$3.36M derived: sum of 3 quarters · filed 2025-05-19 | -$5.05M derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $345.14K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | -$1.29M derived: sum of 2 quarters · filed 2025-04-14 | -$2.98M derived: sum of 3 quarters · filed 2025-04-14 | -$5.81M 10-K · filed 2025-04-14 |
| 2023-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$3.33M derived: sum of 2 quarters · filed 2024-11-07 | -$6.15M 10-Q · filed 2024-11-07 | -$6.36M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$4.52M 10-Q · filed 2024-08-06 | -$4.73M derived: sum of 3 quarters · filed 2024-08-06 | -$6.98M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$2.83M 10-Q · filed 2024-05-07 | -$3.03M derived: sum of 2 quarters · filed 2024-05-07 | -$5.29M derived: sum of 3 quarters · filed 2024-05-07 | -$7.27M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$207.35K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$2.46M derived: sum of 2 quarters · filed 2024-03-13 | -$4.44M derived: sum of 3 quarters · filed 2024-03-13 | -$5.82M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$4.23M derived: sum of 2 quarters · filed 2023-11-02 | -$5.61M 10-Q · filed 2023-11-02 | -$6.93M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$3.35M 10-Q · filed 2023-08-02 | -$4.67M derived: sum of 3 quarters · filed 2023-08-02 | -$10.75M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$1.38M 10-Q · filed 2023-05-04 | -$2.70M derived: sum of 2 quarters · filed 2023-05-04 | -$8.78M derived: sum of 3 quarters · filed 2023-05-04 | -$11.92M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$1.32M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | -$7.40M derived: sum of 2 quarters · filed 2023-03-30 | -$10.54M derived: sum of 3 quarters · filed 2023-03-30 | -$10.67M 10-K/A · filed 2023-03-30 |
| 2021-09-30 | -$6.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$9.22M derived: sum of 2 quarters · filed 2022-11-08 | -$9.35M 10-Q · filed 2022-11-08 | -$9.37M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$3.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$3.27M 10-Q · filed 2022-08-04 | -$3.29M derived: sum of 3 quarters · filed 2022-08-04 | -$3.61M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$126.25K 10-Q · filed 2022-05-10 | -$150.90K derived: sum of 2 quarters · filed 2022-05-10 | -$470.31K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$24.65K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$344.06K derived: sum of 2 quarters · filed 2022-03-22 | -$288.38K 10-K · filed 2022-03-22 | |
| 2020-09-30 | -$319.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$263.73K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $55.68K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |